Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse U-shaped BMI trajectory.

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.

Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023.

Combat exposure was associated with a 12% increase in insomnia risk and 48% increase in sleep apnea risk among active-duty soldiers.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In 2021, there were an estimated 192,000 global cases of pulmonary arterial hypertension, and 62% of these were in female patients. Pulmonary arterial hypertension (PAH) disproportionately affects ...

Influenza-related hospitalization rates in the US varied significantly from 2010/2011 through the 2022/2023, an MMWR report found.